Literature DB >> 26110513

Identifying in vivo DCE MRI markers associated with microvessel architecture and gleason grades of prostate cancer.

Asha Singanamalli1, Mirabela Rusu1, Rachel E Sparks2, Natalie N C Shih3, Amy Ziober3, Li-Ping Wang3, John Tomaszewski4, Mark Rosen5, Michael Feldman3, Anant Madabhushi1.   

Abstract

BACKGROUND: To identify computer extracted in vivo dynamic contrast enhanced (DCE) MRI markers associated with quantitative histomorphometric (QH) characteristics of microvessels and Gleason scores (GS) in prostate cancer.
METHODS: This study considered retrospective data from 23 biopsy confirmed prostate cancer patients who underwent 3 Tesla multiparametric MRI before radical prostatectomy (RP). Representative slices from RP specimens were stained with vascular marker CD31. Tumor extent was mapped from RP sections onto DCE MRI using nonlinear registration methods. Seventy-seven microvessel QH features and 18 DCE MRI kinetic features were extracted and evaluated for their ability to distinguish low from intermediate and high GS. The effect of temporal sampling on kinetic features was assessed and correlations between those robust to temporal resolution and microvessel features discriminative of GS were examined.
RESULTS: A total of 12 microvessel architectural features were discriminative of low and intermediate/high grade tumors with area under the receiver operating characteristic curve (AUC) > 0.7. These features were most highly correlated with mean washout gradient (WG) (max rho = -0.62). Independent analysis revealed WG to be moderately robust to temporal resolution (intraclass correlation coefficient [ICC] = 0.63) and WG variance, which was poorly correlated with microvessel features, to be predictive of low grade tumors (AUC = 0.77). Enhancement ratio was the most robust (ICC = 0.96) and discriminative (AUC = 0.78) kinetic feature but was moderately correlated with microvessel features (max rho = -0.52).
CONCLUSION: Computer extracted features of prostate DCE MRI appear to be correlated with microvessel architecture and may be discriminative of low versus intermediate and high GS.
© 2015 Wiley Periodicals, Inc.

Entities:  

Keywords:  DCE MRI; Gleason grades; imaging biomarkers; microvessel architecture; prostate cancer; quantitative histomorphometry

Mesh:

Substances:

Year:  2015        PMID: 26110513      PMCID: PMC4691230          DOI: 10.1002/jmri.24975

Source DB:  PubMed          Journal:  J Magn Reson Imaging        ISSN: 1053-1807            Impact factor:   4.813


  33 in total

1.  Interobserver reproducibility of Gleason grading of prostatic carcinoma: general pathologist.

Authors:  W C Allsbrook; K A Mangold; M H Johnson; R B Lane; C G Lane; J I Epstein
Journal:  Hum Pathol       Date:  2001-01       Impact factor: 3.466

2.  High-throughput biomarker segmentation on ovarian cancer tissue microarrays via hierarchical normalized cuts.

Authors:  Andrew Janowczyk; Sharat Chandran; Rajendra Singh; Dimitra Sasaroli; George Coukos; Michael D Feldman; Anant Madabhushi
Journal:  IEEE Trans Biomed Eng       Date:  2011-12-13       Impact factor: 4.538

3.  Comprehensive report on prostate cancer misclassification by 16 currently used low-risk and active surveillance criteria.

Authors:  Jüri R Palisaar; Joachim Noldus; Björn Löppenberg; Christian von Bodman; Florian Sommerer; Thilo Eggert
Journal:  BJU Int       Date:  2012-02-07       Impact factor: 5.588

4.  Guideline for the management of clinically localized prostate cancer: 2007 update.

Authors:  Ian Thompson; James Brantley Thrasher; Gunnar Aus; Arthur L Burnett; Edith D Canby-Hagino; Michael S Cookson; Anthony V D'Amico; Roger R Dmochowski; David T Eton; Jeffrey D Forman; S Larry Goldenberg; Javier Hernandez; Celestia S Higano; Stephen R Kraus; Judd W Moul; Catherine M Tangen
Journal:  J Urol       Date:  2007-06       Impact factor: 7.450

5.  Long-term follow-up of a large active surveillance cohort of patients with prostate cancer.

Authors:  Laurence Klotz; Danny Vesprini; Perakaa Sethukavalan; Vibhuti Jethava; Liying Zhang; Suneil Jain; Toshihiro Yamamoto; Alexandre Mamedov; Andrew Loblaw
Journal:  J Clin Oncol       Date:  2014-12-15       Impact factor: 44.544

6.  Prognostic value of microvessel density in prostate cancer: a tissue microarray study.

Authors:  Andreas Erbersdobler; Hendrik Isbarn; Kira Dix; Isabel Steiner; Thorsten Schlomm; Martina Mirlacher; Guido Sauter; Alexander Haese
Journal:  World J Urol       Date:  2009-08-28       Impact factor: 4.226

Review 7.  Risk of Gleason grade inaccuracies in prostate cancer patients eligible for active surveillance.

Authors:  Ronald H Shapiro; Peter A S Johnstone
Journal:  Urology       Date:  2012-09       Impact factor: 2.649

8.  Gleason score and lethal prostate cancer: does 3 + 4 = 4 + 3?

Authors:  Jennifer R Stark; Sven Perner; Meir J Stampfer; Jennifer A Sinnott; Stephen Finn; Anna S Eisenstein; Jing Ma; Michelangelo Fiorentino; Tobias Kurth; Massimo Loda; Edward L Giovannucci; Mark A Rubin; Lorelei A Mucci
Journal:  J Clin Oncol       Date:  2009-05-11       Impact factor: 44.544

9.  Cascaded discrimination of normal, abnormal, and confounder classes in histopathology: Gleason grading of prostate cancer.

Authors:  Scott Doyle; Michael D Feldman; Natalie Shih; John Tomaszewski; Anant Madabhushi
Journal:  BMC Bioinformatics       Date:  2012-10-30       Impact factor: 3.169

10.  Recent trends in prostate cancer incidence by age, cancer stage, and grade, the United States, 2001-2007.

Authors:  Jun Li; Joseph A Djenaba; Ashwini Soman; Sun Hee Rim; Viraj A Master
Journal:  Prostate Cancer       Date:  2012-11-27
View more
  12 in total

1.  Open access image repositories: high-quality data to enable machine learning research.

Authors:  F Prior; J Almeida; P Kathiravelu; T Kurc; K Smith; T J Fitzgerald; J Saltz
Journal:  Clin Radiol       Date:  2019-04-28       Impact factor: 2.350

2.  An Image Analysis Resource for Cancer Research: PIIP-Pathology Image Informatics Platform for Visualization, Analysis, and Management.

Authors:  Anne L Martel; Dan Hosseinzadeh; Caglar Senaras; Yu Zhou; Azadeh Yazdanpanah; Rushin Shojaii; Emily S Patterson; Anant Madabhushi; Metin N Gurcan
Journal:  Cancer Res       Date:  2017-11-01       Impact factor: 12.701

3.  Radiomic features for prostate cancer detection on MRI differ between the transition and peripheral zones: Preliminary findings from a multi-institutional study.

Authors:  Shoshana B Ginsburg; Ahmad Algohary; Shivani Pahwa; Vikas Gulani; Lee Ponsky; Hannu J Aronen; Peter J Boström; Maret Böhm; Anne-Maree Haynes; Phillip Brenner; Warick Delprado; James Thompson; Marley Pulbrock; Pekka Taimen; Robert Villani; Phillip Stricker; Ardeshir R Rastinehad; Ivan Jambor; Anant Madabhushi
Journal:  J Magn Reson Imaging       Date:  2016-12-19       Impact factor: 4.813

4.  Coregistration of Preoperative MRI with Ex Vivo Mesorectal Pathology Specimens to Spatially Map Post-treatment Changes in Rectal Cancer Onto In Vivo Imaging: Preliminary Findings.

Authors:  Jacob Antunes; Satish Viswanath; Justin T Brady; Benjamin Crawshaw; Pablo Ros; Scott Steele; Conor P Delaney; Raj Paspulati; Joseph Willis; Anant Madabhushi
Journal:  Acad Radiol       Date:  2018-01-19       Impact factor: 3.173

5.  Bi-parametric magnetic resonance imaging based radiomics for the identification of benign and malignant prostate lesions: cross-vendor validation.

Authors:  Xuefu Ji; Jiayi Zhang; Yuguo Tang; Wei Xia; Wei Shi; Dong He; Jie Bao; Xuedong Wei; Yuhua Huang; Yangchuan Liu; Jyh-Cheng Chen; Xin Gao
Journal:  Phys Eng Sci Med       Date:  2021-06-01

Review 6.  Contrast agents in dynamic contrast-enhanced magnetic resonance imaging.

Authors:  Yuling Yan; Xilin Sun; Baozhong Shen
Journal:  Oncotarget       Date:  2017-06-27

7.  Registration of presurgical MRI and histopathology images from radical prostatectomy via RAPSODI.

Authors:  Mirabela Rusu; Wei Shao; Christian A Kunder; Jeffrey B Wang; Simon J C Soerensen; Nikola C Teslovich; Rewa R Sood; Leo C Chen; Richard E Fan; Pejman Ghanouni; James D Brooks; Geoffrey A Sonn
Journal:  Med Phys       Date:  2020-07-18       Impact factor: 4.071

Review 8.  Trends in targeted prostate brachytherapy: from multiparametric MRI to nanomolecular radiosensitizers.

Authors:  Alexandru Mihai Nicolae; Niranjan Venugopal; Ananth Ravi
Journal:  Cancer Nanotechnol       Date:  2016-07-04

9.  Identifying the morphologic basis for radiomic features in distinguishing different Gleason grades of prostate cancer on MRI: Preliminary findings.

Authors:  Gregory Penzias; Asha Singanamalli; Robin Elliott; Jay Gollamudi; Natalie Shih; Michael Feldman; Phillip D Stricker; Warick Delprado; Sarita Tiwari; Maret Böhm; Anne-Maree Haynes; Lee Ponsky; Pingfu Fu; Pallavi Tiwari; Satish Viswanath; Anant Madabhushi
Journal:  PLoS One       Date:  2018-08-31       Impact factor: 3.240

10.  Preoperative histogram parameters of dynamic contrast-enhanced MRI as a potential imaging biomarker for assessing the expression of Ki-67 in prostate cancer.

Authors:  Yongsheng Zhang; Zhiping Li; Chen Gao; Jianliang Shen; Mingtao Chen; Yufeng Liu; Zhijian Cao; Peipei Pang; Feng Cui; Maosheng Xu
Journal:  Cancer Med       Date:  2021-06-12       Impact factor: 4.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.